Guideline for Low-Cost Antimicrobial Use in the Outpatient Setting

American Journal of Medicine

Volumn 120, Issue 4, 2007, Pages 295-302

  Hansen, Lizbeth A ^a,b   Vermeulen, Lee C ^a,b   Bland, Sarah ^a   Wetterneck, Tosha B ^c  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Clinical practice guideline; Low cost antimicrobials; Outpatient infections

Indexed keywords

ACICLOVIR; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; BENZAMYCIN; BETA LACTAM ANTIBIOTIC; BISMUTH SALICYLATE; CEFIXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CLOTRIMAZOLE; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FLUCONAZOLE; LEVOFLOXACIN; LOPERAMIDE; MACROLIDE; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN; TETRACYCLINE;

ACNE; ACUTE PYELONEPHRITIS; BRONCHITIS; CHLAMYDIASIS; CHRONIC PROSTATITIS; COMMUNITY ACQUIRED PNEUMONIA; DRUG COST; DRUG EFFICACY; FLUID THERAPY; GENITAL HERPES; GONORRHEA; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HUMAN; INFECTION; LYME DISEASE; OUTPATIENT; PATIENT; PHARYNGITIS; PRIORITY JOURNAL; PROSTATITIS; REVIEW; SINGLE DRUG DOSE; SINUSITIS; TRAVELLER DIARRHEA; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; URINARY TRACT INFECTION; VAGINA CANDIDIASIS; VAGINITIS;

AMBULATORY CARE; ANTI-INFECTIVE AGENTS; FEES, PHARMACEUTICAL; HUMANS; INFECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; TREATMENT OUTCOME; WISCONSIN;

EID: 33947583322     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.06.012     Document Type: Review

References (66)

1. One in Three: Non-Elderly Americans without Health Insurance, 2002-2003 (2004), Families USA Foundation, Washington, DC
2. Regopoulos L.E., and Trude S. Employers shift rising health care costs to workers: no long-term solution in sight. Issue Brief Cent Stud Health Syst Change 83 (2004) 1-4
3. Heisler M., Langa K.N., Eby E.L., Fendrick A.M., Kabeto M.U., and Piette J.D. The health effects of restricting prescription medication use because of cost. Med Care 42 (2004) 626-634
4. Harris Interactive. The impact of tiered co-pays: a survey of patients and pharmacists. Research report. September 2003. Available at: http://www.harrisinteractive.com/news/newsletters/healthnews/HI_HealthCareNews2001Vol1_iss32.pdf. Accessed March 18, 2005.
5. Alexander G.C., Casalino L.P., and Meltzer D.O. Patient-physician communication about out-of-pocket costs. JAMA 290 (2003) 953-958
6. Alexander G.C., Casalino L.P., Tseng C.-W., McFadden D., and Meltzer D.O. Barriers to patient-physician communication about out-of-pocket costs. J Gen Intern Med 19 (2004) 856-860
7. Piette J.D., Heisler M., and Wagner T.H. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care 27 (2004) 384-391
8. Piette J.D., and Heisler M. Problems due to medication costs among VA and non-VA patients with chronic illnesses. Am J Manag Care 10 (2004) 861-868
9. Heisler M., Wagner T.H., and Piette J.D. Patient strategies to cope with high prescription medication costs: who is cutting back on necessities, increasing debt, or underusing medications. J Behav Med 28 (2005) 43-51
10. Reichert S., Simon T., and Halm E.A. Physicians' attitudes about prescribing and knowledge of the costs of common medications. Arch Intern Med 160 (2000) 2799-2803
11. Clauson K.A., Seamon M.J., Clauson A.S., and Van T.B. Evaluation of drug information databases for personal digital assistants. Am J Health Syst Pharm 61 (2004) 1015-1024
12. Rothschild J.M., Lee T.H., Bae T., and Bates D.W. Clinician use of a palmtop drug reference guide. J Am Med Inform Assoc 9 (2002) 223-229
13. Korn L.M., Reichert S., Simon T., and Halm E.A. Improving physicians' knowledge of the costs of common medication and willingness to consider costs when prescribing. J Gen Intern Med 18 (2003) 31-37
14. Depiero A.D., Ochsenschlager D.W., and Chamberlain J.M. Analysis of pediatric hospitalizations after emergency department release as a quality improvement tool. Ann Emerg Med 39 (2002) 159-163
15. Taira D.A., Iwane K.A., and Chung R.S. Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents to type of coverage. Am J Manag Care 9 (2003) 305-312
16. Matsuli D., Joubert G.I., Dykxhoorn S., and Rieder M.J. Compliance with prescription filling in the pediatric emergency department. Arch Pediatr Adolesc Med 154 (2000) 195-198
17. Thomas E.J., Burstin H.R., O'Neil A.C., Orav E.J., and Brennan T.A. Patient noncompliance with medical advice after the emergency department visit. Ann Emerg Med 27 (1996) 49-55
18. Hass J.A., Phillips K.A., Gerstenberger E.P., and Seger A.C. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med 142 (2005) 891-897
19. th ed. (2004), Antimicrobial Therapy, Inc, Hyde Park, VT
20. Wisconsin Medicaid. Wisconsin Department of Health and Family Services Website. Available at: http://dhfs.wisconsin.gov/medicaid4/pharmacy/data_tables/legend_mac.asp. Accessed July 5, 2005.
21. nd ed. (2000), Churchill Livingstone, Oxford, UK
22. Cheng A.C., and Thielman N.M. Update on traveler's diarrhea. Curr Infect Dis Rep 4 (2002) 70-77
23. Adachi J.A., Ostrosky-Zeichner L., DuPont H.L., and Ericsson C.D. Empirical antimicrobial therapy for traveler's diarrhea. Clin Infect Dis 31 (2000) 1079-1083
24. Caeiro J.P., DuPont H.L., Albrecht H., and Ericsson C.D. Oral rehydration therapy plus loperamide versus loperamide alone in the treatment of traveler's diarrhea. Clin Infect Dis 28 (1999) 1286-1289
25. Fihn S.D. Acute uncomplicated urinary tract infections in women. N Engl J Med 349 (2003) 259-266
26. Warren J.W., Abrutyn E., Hebel R., Johnson J.R., Schaeffer A.J., and Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 29 (1999) 745-758
27. Gupta K., Hooton T.M., and Stamm W.E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 135 (2001) 41-50
28. Centers for Disease Control and Prevention. Sexually transmitted disease guidelines 2002. MMWR Recomm Rep 51 (2002) 1-78
29. Horner P.J., and Caul E.O. National guidelines for the management of Chlamydia trachomatis genital tract infection. Sex Transm Infect 75 (1999) S4-S8
30. Hillis S.D., Coles F.B.D., Litchfield B., et al. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women: a use-effectiveness study in public health settings. Sex Transm Dis 25 (1998) 5-11
31. Bignell C. National guidelines for the management of gonorrhoea in adults. Sex Transm Infect 75 (1999) S13-S15
32. Echols R.M., Heyd A., O'Keeffe B.J., and Schacht P. Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: a worldwide summary. Sex Transm Dis 23 (1996) 165-167
33. Barton S., Brown D., Cowan F., et al. National guidelines for the management of genital herpes. Sex Transm Infect 75 (1999) S24-S28
34. Fife K.H., Barbarash R.A., Rudolph T., Degregorio B., Roth R., and The valacyclovir international herpes simplex virus study group. Valacyclovir versus acyclovir in the treatment of first-episode genital herpes infection: results of an international, multicenter, double-blind, randomized clinical trial. Sex Transm Dis 24 (1997) 481-486
35. Hay P. National guidelines for the management of bacterial vaginosis. Sex Transm Infect 75 (1999) S16-S18
36. Lugo-Miro V.I., Green M., and Mazur L. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis. JAMA 268 (1992) 92-95
37. Daniels D., and Forster G. National guidelines for the management of vulvovaginal candidiasis. Sex Transm Infect 75 (1999) S19-S20
38. De Punzio C., Garutti P., Mollica G., Nappi C., Piccoli R., and Genazzani A.R. Fluconazole 150 mg single dose versus itraconazole 200 mg per day for 3 days in the treatment of acute vaginal candidiasis: a double-blind randomized study. Eur J Obstet Gynecol Reprod Biol 106 (2003) 193-197
39. Sherrard J. National guidelines for the management of Trichomonas vaginalis. Sex Transm Infect 75 (1999) S21-S23
40. Gülmezoglu A.M. Interventions for trichomoniasis in pregnancy. Cochrane Database Syst Rev (2002) 3
41. Hager W.D., Brown S.T., Kraus S.J., Kleris G.S., Perkins G.J., and Henderson M. Metronidazole for vaginal trichomoniasis. Seven-day vs single-dose regimens. JAMA 12 (1980) 1219-1220
42. Walker P., and Wilson J. National guidelines for the management of prostatitis. Sex Transm Infect 75 (1999) S46-S50
43. Fowler J.E. Antimicrobial therapy for bacterial and nonbacterial prostatitis. Urology 20 Suppl 6A (2002) S24-S26
44. Smucny J., Fahey T., Becker L., and Glazier R. Antibiotics for acute bronchitis. The Cochrane Database of Systematic Review [database online] (2000), Cochrane Acute Respiratory Infections Group Updated December 15, 2003
45. Gonzales R., Bartlett J.G., Besser R.E., et al. Principles of appropriate antibiotic use for the treatment of uncomplicated acute bronchitis: background. Ann Emerg Med 37 (2001) 720-727
46. Bisno A.L., Gerber M.A., Gwaltney Jr. J.M., Kaplan E.L., and Schwartz R.H. Practice guidelines for the diagnosis and management of group a streptococcal pharyngitis. Clin Infect Dis 35 (2002) 113-125
47. Cooper R.J., Hoffman J.R., Bartlett J.G., et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Emerg Med 37 (2001) 711-719
48. Mandell L.A., Bartlett J.G., Dowell S.F., File T.M., Musher D.M., and Whitney C. Update of practice guideline for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37 (2003) 1405-1433
49. Ailania R.K., Agastya G., Ailani R.K., Mukunda B.N., and Shekar R. Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia. Arch Intern Med 159 (1999) 266-270
50. Gleason P.P., Kapoor W.N., Stone R.A., et al. Medical outcomes and antimicrobial costs with the use of the American thoracic society guidelines for outpatients with community-acquired pneumonia. JAMA 278 (1997) 32-39
51. Dunbar L.M., Wunderink R.G., Habib M.P., et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 37 (2003) 752-760
52. Dunbar L.M., Khashab M.M., Kahn J.B., Zadeikis N., Ziang J.X., and Tennenberg A.M. Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens. Curr Med Res Opin 20 (2004) 555-563
53. Sánchez F., Mesna J., Martínez A., et al. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?. Clin Infect Dis 36 (2003) 1239-1245
54. Kasbekar N., and Acharya P.S. Telithromycin: the first ketolide for the treatment of respiratory infections. Am J Health Syst Pharm 62 (2005) 905-916
55. Levison M.E., Manura C.T., Lorber B., et al. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med 98 (1983) 466-471
56. Perlino C.A. Metronidazole vs clindamycin treatment of anaerobic pulmonary infection. Failure of metronidazole therapy. Arch Intern Med 141 (1981) 1424-1427
57. Kapila R., Sen P., Salaki J., and Louria D.B. Evaluation of clindamycin and other antibiotics in the treatment of anaerobic bacterial infections of the lung. J Infect Dis 135 suppl (1977) S58-S64
58. Hickner J.M., Barlett J.G., Besser R.E., Gonzales R., Hoffman J.R., and Sande M. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Emerg Med 37 (2001) 703-710
59. Ip S., Fu L., Balk E., Chew P., DeVine D., and Lau J. Update on Acute Bacterial Rhinosinusitis (2005), U.S. Department of Health and Human Services, Rockville, MD
60. Haider A., and Shaw J.C. Treatment of acne vulgaris. JAMA 292 (2004) 726-735
61. Wormser G.P., Nadelman R.B., Dattwyler R.J., et al. Practice guidelines for the treatment of Lyme disease. Clin Infect Dis 31 suppl 1 (2000) S1-S14
62. Wormser G.P., Ramanathan R., Nowakoaski J.M., et al. Duration of antibiotic therapy for early Lyme disease. Ann Intern Med 138 (2003) 697-704
63. Shiffman R.N., Shekelle P., Overhage M., Slutsky J., Grimshaw J., and Deshpande A.M. Standardized reporting of clinical practice guidelines: a proposal from the conference on guideline standardization. Ann Intern Med 139 (2003) 493-498
64. Fischer M.A., and Avorn J. Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans. Health Serv Res 38 (2003) 1051-1063
65. Nutescu E.A., Park H.Y., Walton S.M., et al. Factors that influence prescribing within a therapeutic drug class. J Eval Clin Pract 11 (2005) 357-365
66. Lichtenberg F.R. Are the benefits of newer drugs worth their cost?. Evidence from the 1996 MEPS. Health Aff. (Millwood) 20 (2001) 241-251